Table 3.
Predictor | Univariable Analysis |
Multivariable Analysis |
||||
---|---|---|---|---|---|---|
HR | 95% CI | p Value | HR | 95% CI | p Value | |
Age (10 yrs) | 1.11 | 0.98–1.26 | 0.106 | 1.31 | 1.12–1.52 | <0.001 |
Genotype | ||||||
MYBPC3 | 1.00 | – | – | 1.00 | – | – |
MYH7 | 1.22 | 0.73–2.02 | 0.447 | 1.13 | 0.67–1.92 | 0.644 |
MYL2 | 0.69 | 0.17–2.86 | 0.607 | 0.83 | 0.19–3.57 | 0.801 |
TNNI3 | 0.22 | 0.08–0.62 | 0.004 | 0.19 | 0.07–0.55 | 0.002 |
TNNT2 | 0.97 | 0.49–1.90 | 0.927 | 0.67 | 0.34–1.33 | 0.249 |
TPM1 | 0.78 | 0.24–2.53 | 0.677 | 0.41 | 0.12–1.39 | 0.152 |
ACTC1 | 8.91 | 1.19–66.91 | 0.034 | 13.51 | 1.67–109.14 | 0.015 |
Multiple mutations | 0.84 | 0.20–3.49 | 0.806 | 1.22 | 0.29–5.21 | 0.786 |
Male | 2.03 | 1.32–3.14 | 0.001 | 2.91 | 1.82–4.65 | <0.001 |
Abnormal ECG∗ | 3.11 | 2.03–4.76 | <0.001 | 4.02 | 2.51–6.44 | <0.001 |
CMR | 1.38 | 0.89–2.12 | 0.148 | Analysis stratified for CMR | ||
Hypertension | 1.90 | 0.87–4.14 | 0.107 | - |
CI = confidence interval; HR = hazard ratio; other abbreviations as in Table 1.
At baseline or during follow-up.